Over 75 jobs are anticipated to be generated when the new plant-based medicine production facility, developed by Cannatrek at Lemnos, becomes fully operational.
On April 14, Regional Development Minister Mary-Anne Thomas visited the facility to announce a grant from the Victorian Government’s Regional Jobs Fund for Cannatrek.
Established in 2016, the Australian-owned company produces plant-based medicine at its Queensland research and development greenhouse facility for over 6,000 patients.
The Greater Shepparton development will be the first production facility located outside of Queensland.
This project will enable Cannatrek to depend on locally produced plant-based medicine from Australia rather than relying on imports.
Information about studies provided by Cannatrek on this website is for education purposes only. It is not a substitute for professional health advice. Nothing contained in this site, or any external site linked to by Cannatrek, is intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional’s advice. Cannatrek does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information provided on this website, or any external site linked to by Cannatrek. Further, Cannatrek accepts no responsibility for material contained in a website that is linked to this site. It is the responsibility of the user to make their own decisions about the accuracy, currency, reliability and correctness of information contained in linked external websites.